• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寡突胶质细胞瘤的单细胞分辨率下的空间代谢异质性。

Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution.

机构信息

Cooper Medical School, Rowan University, Camden, NJ, USA.

College of Medicine, University of Florida, Gainesville, FL, USA.

出版信息

Brain Tumor Pathol. 2023 Apr;40(2):101-108. doi: 10.1007/s10014-023-00455-8. Epub 2023 Apr 11.

DOI:10.1007/s10014-023-00455-8
PMID:37041322
Abstract

Oligodendrogliomas are a type of rare and incurable gliomas whose metabolic profiles have yet to be fully examined. The present study examined the spatial differences in metabolic landscapes underlying oligodendrogliomas and should provide unique insights into the metabolic characteristics of these uncommon tumors. Single-cell RNA-sequencing expression profiles from 4044 oligodendroglioma cells derived from tumors resected from four locations frontal, temporal, parietal, and frontotemporoinsular) and in which 1p/19q co-deletion and IDH1 or IDH2 mutations were confirmed were computationally analyzed through a robust workflow to elucidate relative differences in metabolic pathway activities among the different locations. Dimensionality reduction using metabolic expression profiles exhibited clustering corresponding to each location subgroup. From the 80 metabolic pathways examined, over 70 pathways had significantly different activity scores between location subgroups. Further analysis of metabolic heterogeneity suggests that mitochondrial oxidative phosphorylation accounts for considerable metabolic variation within the same locations. Steroid and fatty acid metabolism pathways were also found to be major contributors to heterogeneity. Oligodendrogliomas display distinct spatial metabolic differences in addition to intra-location metabolic heterogeneity.

摘要

少突胶质细胞瘤是一种罕见且无法治愈的神经胶质瘤,其代谢特征尚未被充分研究。本研究检测了源于额叶、颞叶、顶叶和额颞顶枕叶四个部位切除肿瘤的 4044 个少突胶质细胞瘤细胞的代谢景观的空间差异,这应该为这些罕见肿瘤的代谢特征提供独特的见解。通过稳健的工作流程对经计算分析确认 1p/19q 共缺失和 IDH1 或 IDH2 突变的肿瘤中 4044 个少突胶质细胞瘤细胞的单细胞 RNA 测序表达谱进行分析,以阐明不同部位之间代谢途径活性的相对差异。使用代谢表达谱进行降维,表现出与每个位置亚组相对应的聚类。在所检查的 80 条代谢途径中,有 70 多条途径在位置亚组之间的活性评分存在显著差异。对代谢异质性的进一步分析表明,线粒体氧化磷酸化是同一部位内代谢变异的主要原因。固醇和脂肪酸代谢途径也是异质性的主要贡献者。除了位置内的代谢异质性外,少突胶质细胞瘤还表现出明显的空间代谢差异。

相似文献

1
Spatial metabolic heterogeneity of oligodendrogliomas at single-cell resolution.寡突胶质细胞瘤的单细胞分辨率下的空间代谢异质性。
Brain Tumor Pathol. 2023 Apr;40(2):101-108. doi: 10.1007/s10014-023-00455-8. Epub 2023 Apr 11.
2
Concurrent CIC mutations, IDH mutations, and 1p/19q loss distinguish oligodendrogliomas from other cancers.同时存在 CIC 突变、IDH 突变和 1p/19q 缺失可将少突胶质细胞瘤与其他癌症区分开来。
J Pathol. 2012 Jan;226(1):7-16. doi: 10.1002/path.2995. Epub 2011 Nov 10.
3
Utility of targeted next-generation sequencing assay to detect 1p/19q co-deletion in formalin-fixed paraffin-embedded glioma specimens.靶向二代测序检测法在福尔马林固定石蜡包埋脑胶质瘤标本中检测 1p/19q 共缺失的效用。
Hum Pathol. 2022 Aug;126:63-76. doi: 10.1016/j.humpath.2022.05.001. Epub 2022 May 10.
4
Loss of H3K27 trimethylation is frequent in IDH1-R132H but not in non-canonical IDH1/2 mutated and 1p/19q codeleted oligodendroglioma: a Japanese cohort study.IDH1-R132H 突变型而非非典型 IDH1/2 突变和 1p/19q 联合缺失型少突胶质细胞瘤中频繁出现 H3K27 三甲基化丢失:一项日本队列研究。
Acta Neuropathol Commun. 2021 May 21;9(1):95. doi: 10.1186/s40478-021-01194-7.
5
Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.1p/19q 共缺失的间变性少突胶质细胞瘤中的对比增强与 9p 缺失、基因组不稳定和血管生成基因表达相关。
Neuro Oncol. 2014 May;16(5):662-70. doi: 10.1093/neuonc/not235. Epub 2013 Dec 18.
6
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.胶质瘤中1p36和19q13的等位基因缺失:与组织学分类的相关性、1p36上150kb最小缺失区域的定义以及CAMTA1作为候选肿瘤抑制基因的评估
Clin Cancer Res. 2005 Feb 1;11(3):1119-28.
7
Combining two biomarkers, IDH1/2 mutations and 1p/19q codeletion, to stratify anaplastic oligodendroglioma in three groups: a single-center experience.联合两种生物标志物,即 IDH1/2 突变和 1p/19q 共缺失,将间变性少突胶质细胞瘤分为三组:单中心经验。
J Neurooncol. 2013 Aug;114(1):85-91. doi: 10.1007/s11060-013-1152-0. Epub 2013 May 17.
8
Network-based analysis of oligodendrogliomas predicts novel cancer gene candidates within the region of the 1p/19q co-deletion.基于网络的少突胶质细胞瘤分析预测了 1p/19q 共缺失区域内的新癌症基因候选物。
Acta Neuropathol Commun. 2018 Jun 11;6(1):49. doi: 10.1186/s40478-018-0544-y.
9
Mitotic index, microvascular proliferation, and necrosis define 3 groups of 1p/19q codeleted anaplastic oligodendrogliomas associated with different genomic alterations.有丝分裂指数、微血管增殖和坏死将1p/19q共缺失的间变性少突胶质细胞瘤分为3组,这些组与不同的基因组改变相关。
Neuro Oncol. 2014 Sep;16(9):1244-54. doi: 10.1093/neuonc/nou047. Epub 2014 Apr 9.
10
Morphologically, genetically and spatially mixed astrocytoma and oligodendroglioma; chronological acquisition of 1p/19q codeletion and CDKN2A deletion: a case report.形态学、遗传学和空间上混合的星形细胞瘤和少突胶质细胞瘤;1p/19q共缺失和CDKN2A缺失的时间顺序获得:一例报告
Brain Tumor Pathol. 2023 Jan;40(1):26-34. doi: 10.1007/s10014-022-00448-z. Epub 2022 Dec 26.

引用本文的文献

1
Immuno-oncological interactions between meningeal lymphatics and glioblastoma: from mechanisms to therapies.脑膜淋巴管与胶质母细胞瘤之间的免疫肿瘤学相互作用:从机制到治疗
Theranostics. 2025 Jun 9;15(14):6983-7000. doi: 10.7150/thno.111972. eCollection 2025.
2
Recent Developments in Single-Cell Metabolomics by Mass Spectrometry─A Perspective.基于质谱的单细胞代谢组学研究进展——综述
J Proteome Res. 2025 Apr 4;24(4):1493-1518. doi: 10.1021/acs.jproteome.4c00646. Epub 2024 Oct 22.
3
In Vitro Effects of Methylprednisolone over Oligodendroglial Cells: Foresight to Future Cell Therapies.

本文引用的文献

1
Surveying brain tumor heterogeneity by single-cell RNA-sequencing of multi-sector biopsies.通过多区域活检的单细胞RNA测序来研究脑肿瘤异质性。
Natl Sci Rev. 2020 Aug;7(8):1306-1318. doi: 10.1093/nsr/nwaa099. Epub 2020 May 30.
2
Uncovering Spatiotemporal Heterogeneity of High-Grade Gliomas: From Disease Biology to Therapeutic Implications.揭示高级别胶质瘤的时空异质性:从疾病生物学到治疗意义
Front Oncol. 2021 Aug 5;11:703764. doi: 10.3389/fonc.2021.703764. eCollection 2021.
3
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.
甲基强的松龙对少突胶质细胞的体外作用:对未来细胞治疗的展望。
Cells. 2023 May 30;12(11):1515. doi: 10.3390/cells12111515.
2021 年世卫组织中枢神经系统肿瘤分类:概述。
Neuro Oncol. 2021 Aug 2;23(8):1231-1251. doi: 10.1093/neuonc/noab106.
4
Emerging Roles and Therapeutic Interventions of Aerobic Glycolysis in Glioma.有氧糖酵解在胶质瘤中的新兴作用及治疗干预
Onco Targets Ther. 2020 Jul 16;13:6937-6955. doi: 10.2147/OTT.S260376. eCollection 2020.
5
Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis.单细胞分析揭示原发性 IDH 野生型胶质母细胞瘤的肿瘤内和肿瘤间异质性对分子特征的影响。
CNS Neurosci Ther. 2020 Sep;26(9):981-989. doi: 10.1111/cns.13396. Epub 2020 Jun 2.
6
Metabolic Variations between Low-Grade and High-Grade Gliomas-Profiling by H NMR Spectroscopy.低级别与高级别神经胶质瘤的代谢差异:基于~1H NMR 波谱分析。
J Proteome Res. 2020 Jun 5;19(6):2483-2490. doi: 10.1021/acs.jproteome.0c00243. Epub 2020 May 22.
7
Targeting glioma-initiating cells via the tyrosine metabolic pathway.通过酪氨酸代谢途径靶向神经胶质瘤起始细胞。
J Neurosurg. 2020 Feb 14;134(3):721-732. doi: 10.3171/2019.11.JNS192028. Print 2021 Mar 1.
8
Defining a metabolic landscape of tumours: genome meets metabolism.定义肿瘤的代谢景观:基因组与代谢。
Br J Cancer. 2020 Jan;122(2):136-149. doi: 10.1038/s41416-019-0663-7. Epub 2019 Dec 10.
9
Single-cell RNA-seq reveals the invasive trajectory and molecular cascades underlying glioblastoma progression.单细胞 RNA 测序揭示了胶质母细胞瘤进展的浸润轨迹和分子级联反应。
Mol Oncol. 2019 Dec;13(12):2588-2603. doi: 10.1002/1878-0261.12569. Epub 2019 Sep 17.
10
Metabolic landscape of the tumor microenvironment at single cell resolution.肿瘤微环境的代谢全景图,单细胞分辨率。
Nat Commun. 2019 Aug 21;10(1):3763. doi: 10.1038/s41467-019-11738-0.